| Detected | Trial | Change |
|---|---|---|
| 2026-06-06 | NCT05891171 Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers |
date change Primary completion pushed: 2026-03 -> 2027-09 |
| 2026-06-06 | NCT05891171 Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers |
date change Completion pushed: 2026-03 -> 2027-09 |
| 2026-06-02 | NCT05633667 Study of Novel Treatment Combinations in Patients With Lung Cancer |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-02 | NCT05633667 Study of Novel Treatment Combinations in Patients With Lung Cancer |
Enrollment reduced: 270 -> 192 participants |
| 2026-06-02 | NCT05633667 Study of Novel Treatment Combinations in Patients With Lung Cancer |
Trial sites reduced: 100 -> 89 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-02 | NCT07619313 AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients… | Phase 1 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06431633 | Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer… | Lung Diseases | Recruiting |
| NCT05502237 | Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With… | Non-small Cell Lung Cancer | Active, Not Recruiting |
| NCT05568095 | A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus… | Advanced Upper Gastrointestinal Tract Adenocarcinoma | Active, Not Recruiting |
| Phase 2 | |||
| NCT06048133 | Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced… | Biliary Tract Carcinoma | Recruiting |
| NCT06048484 | Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma | Pancreatic Ductal Adenocarcinoma | Recruiting |
| NCT03547973 | Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be… | Metastatic Urothelial Cancer | Recruiting |
| NCT07397611 | Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC | Renal Cell Carcinoma | Recruiting |
| NCT06727565 | Study of Novel Treatment Combination Therapies in Participants With Head and Neck… | Head and Neck Squamous Cell Carcinoma | Active, Not Recruiting |
| NCT05335941 | A Phase 2 Study to Evaluate the Triplet Combination of Pemetrexed Plus AB928… | Urothelial Carcinoma | Active, Not Recruiting |
| NCT05824468 | Zimberelimab Plus Lenvatinib After Progression on Prior Immune Checkpoint Inhibitors for… | Cervical Cancer | Active, Not Recruiting |
| NCT06133517 | PeRioperative Immunotherapy Combined With Sacituzumab Govitecan in Muscle Invasive… | Urothelial Bladder Carcinoma | Active, Not Recruiting |
| NCT05130177 | Zimberelimab (AB122) With TIGIT Inhibitor Domvanalimab (AB154) in PD-1… | Melanoma | Active, Not Recruiting |
| NCT04736173 | Study Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung Cancer | Non Small Cell Lung Cancer | Active, Not Recruiting |
| NCT05633667 | Study of Novel Treatment Combinations in Patients With Lung Cancer | Lung Cancer | Active, Not Recruiting |
| NCT05676931 | Study With Various Immunotherapy Treatments in Participants With Lung Cancer | Advanced Non-Small Cell Lung Cancer | Active, Not Recruiting |
| NCT05329766 | A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in… | Gastrointestinal Tract Malignancies | Active, Not Recruiting |
| NCT04791839 | Safety and Efficacy of Zimberelimab (AB122) in Combination With Domvanalimab (AB154) and… | Non Small Cell Lung Cancer | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT05688215 | Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of… | Borderline Resectable Pancreatic Adenocarcinoma | Recruiting |
| Phase 1 | |||
| NCT05007782 | Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced… | Advanced Solid Tumor | Recruiting |
| NCT06759649 | A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies | Neoplasm | Recruiting |
| NCT06532565 | Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors | Advanced Solid Tumors | Recruiting |
| NCT05536141 | A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma… | Clear Cell Renal Cell Carcinoma | Recruiting |
| NCT05840224 | Study of GS-4528 in Adults With Solid Tumors | Solid Tumor | Active, Not Recruiting |
| NCT06082960 | Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors | Solid Tumors | Active, Not Recruiting |
| NCT04104672 | A Study to Evaluate the Safety and Tolerability of AB680 in Participants With… | Advanced Pancreatic Cancer | Active, Not Recruiting |